-- Preview Email Newsletter
| *Maryland Editor Tipoffs Newsletter for 2025-06-15 ( 4 items ) |
|
CPSC Commissioner Trumka Declares Court Reinstatement a Win for Consumer Safety (10)
WASHINGTON, June 14 -- Consumer Product Safety Commission commissioner Richard Trumka Jr. issued a statement celebrating a U.S. District Court ruling that declared his firing by the President unlawful, restoring him and his colleagues to their positions.
Trumka reaffirmed CPSC's independence and recommitted to advancing safety initiatives previously stalled by the attempted removal, including addressing hazards from lithium-ion batteries, button batteries, infant rockers, and other consumer pr more PR
Justice Department Issues Notice on Customer Experience Hub Membership (10)
WASHINGTON, June 14 (TNSFR) -- The Department of Justice Antitrust Division has issued a notice entitled "National Cooperative Research and Production Act of 1993--Customer Experience Hub."
This notice states that on April 1, 2025, the Customer Experience Hub filed notifications regarding changes to its membership. This action was taken to extend the protections of the National Cooperative Research and Production Act, which limits recovery for antitrust plaintiffs to actual damages under specif more PR
Office of Postsecondary Education Seeks Public Input on Campus Athletics Equity Survey Information Collection (10)
WASHINGTON, June 15 (TNSFRinfo) -- The U.S. Department of Education Office of Postsecondary Education has issued an information collection notice entitled "Campus Equity in Athletics Disclosure Act Survey."
This notice proposes an extension without change of a currently approved information collection request. It is being conducted in accordance with the Paperwork Reduction Act of 1995. The Department of Education is seeking public comments to help assess the impact of its information collectio more PR
U.S. Drug Supply Chains Face Deep Vulnerabilities, Company Warns (10)
WASHINGTON, June 15 -- On Demand Pharmaceuticals, Rockville, Maryland, has submitted an analysis to the U.S. Department of Commerce Bureau of Industry and Security, outlining vulnerabilities within the nation's drug supply chains. The company states that the availability of essential medicines rests on assumptions that no longer hold, masking deeper issues across economic, structural and geopolitical lines.
The company's assessment highlights that the U.S. heavily relies on global supply chains more ST
|
